GT health — Wise Endocrine & Obesity Care

Patient MessagingPatients

Dr. Tashko’s 3D infographic on fibromuscular dysplasia showing a young female silhouette with highlighted renal artery displaying the classic “string-of-beads” appearance, alongside visual emphasis on the heart and kidney. A soft ECG waveform overlays the chest, while a molecular and vascular network background conveys systemic vascular involvement and the interconnected nature of arterial health in women.

Fibromuscular dysplasia, FMD, represents a non-inflammatory and non-atherosclerotic arterial disease that affects medium-sized arteries. It most commonly involves the renal and carotid arteries. Although men can develop FMD, women account for approximately 80–90% of diagnosed cases.

This striking gender predominance shapes how we approach evaluation. In women with unexplained hypertension, pulsatile tinnitus, or arterial dissection at a young age, FMD deserves thoughtful consideration.

As an endocrinologist and clinical hypertension specialist, I view blood pressure through a broader physiologic lens. Hormones, vascular biology, and sympathetic tone interact. Fibromuscular dysplasia sits within that larger vascular context.

What Is Fibromuscular Dysplasia?

Fibromuscular dysplasia involves abnormal cellular growth within the arterial wall. This growth narrows segments of the artery, often alternating with small aneurysmal dilations. On imaging, the classic appearance resembles a “string-of-beads” pattern.

The renal arteries remain the most commonly affected site. However, FMD can also involve:

  • Carotid arteries
  • Vertebral arteries
  • Mesenteric arteries
  • Iliac arteries

Importantly, FMD differs from atherosclerosis. It does not arise from cholesterol plaque. Instead, it reflects structural arterial remodeling.

Why Is FMD More Common in Women?

The exact cause remains unclear. However, several observations guide our thinking. Data from the United States Registry for FMD highlight clear demographic trends.

About 91% of diagnosed patients are female. Approximately 95% identify as White, while Hispanic patients make up about 2%, Black patients about 1.5%, and Asian patients about 1%. These figures likely reflect both biological patterns and disparities in access to advanced imaging.

  1. Hormonal Influence: Most patients are women between 20–60 years old. This pattern suggests that estrogen or other hormone-related factors may influence vascular remodeling. Researchers continue to explore this connection.
  2. Genetic Susceptibility: Family clustering occurs in a minority of cases. While no single gene explains most cases, inherited vascular vulnerability likely plays a role.
  3. Mechanical Stress and Arterial Structure: Women generally have smaller vessel diameters compared to men. Subtle differences in connective-tissue architecture may contribute to susceptibility.

A balanced viewpoint recognizes that FMD likely results from multiple interacting factors rather than a single trigger.

Renal Artery FMD and Hypertension in Women

Renal artery involvement often presents as secondary hypertension. A 32-year-old woman with new-onset blood pressure of 165/95 mmHg and no strong family history should prompt a deeper evaluation.

When renal blood flow decreases due to arterial narrowing, the kidney activates the renin-angiotensin-aldosterone system (RAAS). Renin rises. Angiotensin II constricts vessels. Aldosterone promotes sodium retention. Blood pressure increases.

This mechanism differs from essential hypertension. Treating only the surface number may miss the underlying driver. Clues that suggest renal FMD include:

  • Onset of hypertension before age 40
  • Resistant hypertension despite 2–3 medications
  • Abdominal bruit
  • Unexplained kidney asymmetry on imaging

In selected patients, CT angiography or MR angiography confirms the diagnosis.

Cerebrovascular FMD in Women

Carotid or vertebral involvement may produce very different symptoms. Women often report:

  • Pulsatile tinnitus, a rhythmic “whooshing” in the ear
  • Headaches
  • Neck pain
  • Dizziness

In rare cases, arterial dissection or stroke occurs. While this remains uncommon, the association underscores why early recognition matters.

Importantly, many women with cerebrovascular FMD maintain normal cholesterol and lack traditional vascular risk factors. This distinction reinforces that FMD is not an atherosclerotic disease.

Fibromuscular dysplasia also associates with spontaneous coronary artery dissection, SCAD, another vascular condition that disproportionately affects women.

How We Evaluate Suspected FMD

Evaluation begins with pattern recognition. We look for atypical hypertension patterns in younger women. We also consider unexplained neurologic symptoms or arterial dissections.

CT angiography often provides excellent visualization of the “string-of-beads” pattern. Duplex ultrasound can serve as a screening tool in renal arteries, although it may miss distal lesions.

Because FMD can affect multiple vascular beds, comprehensive imaging from head-to-pelvis may be appropriate after diagnosis. This strategy identifies additional areas of involvement. A thoughtful approach avoids both under-recognition and over-testing.

Management Principles in Women With FMD

Management depends on location and severity. Renal FMD often responds well to ACE inhibitors or angiotensin-receptor blockers. These medications target the renin-driven mechanism directly.

In selected women with significant renal artery stenosis and uncontrolled hypertension, balloon angioplasty without stenting can improve blood pressure substantially. Some patients reduce or discontinue medications afterward.

Low-dose aspirin may reduce thrombotic risk in certain patients, particularly those with cerebrovascular involvement. Although FMD is not plaque-driven, maintaining optimal lipids, glucose, and blood pressure supports overall vascular resilience.

Patient Case Variations

  • Case 1 — Young Woman With Resistant Hypertension: A 29-year-old woman presents with blood pressure 170/100 mmHg despite two medications. Imaging reveals right renal artery beading. Angioplasty improves her pressure to 125/80 mmHg with one medication.
  • Case 2 — Pulsatile Tinnitus Presentation: A 41-year-old woman reports rhythmic ear noise and headaches. Carotid imaging confirms FMD without severe stenosis. Conservative management and aspirin stabilize her course.
  • Case 3 — Postpartum Blood Pressure Escalation: A 34-year-old woman develops persistent hypertension after pregnancy. Evaluation shows renal FMD. Targeted therapy normalizes renin-driven activation.
  • Case 4 — Incidental Finding: A 52-year-old woman undergoes CT imaging for abdominal pain. Radiology notes mild renal artery beading. Her blood pressure remains controlled. Observation and monitoring prove sufficient.
  • Case 5 — Arterial Dissection Event: A 38-year-old athletic woman develops sudden neck pain and transient neurologic symptoms. Imaging reveals vertebral artery dissection associated with FMD. Prompt management prevents long-term deficits.

Summary Table

FeatureWomen With Renal FMDWomen With Carotid FMD
Common Age20–50 years30–60 years
Primary SymptomHypertensionPulsatile tinnitus, headache
MechanismRenin activationArterial remodeling
InterventionACE inhibitor, angioplastyObservation, aspirin if indicated

The Broader Context

Fibromuscular dysplasia reminds us that not all vascular disease reflects cholesterol or lifestyle alone. In women, particularly younger women, structural arterial disorders require careful attention.

Recognizing FMD early can shift management from symptom control to mechanism-based treatment. That shift represents a meaningful approach rather than a reactive one.

At our practice in Montgomery County, Maryland, and through virtual care, we evaluate secondary hypertension and vascular conditions through personalized, comprehensive assessment. We integrate imaging, laboratory patterns, and hormonal context to guide a smart strategy tailored to each patient’s physiology.

Dr. Tashko

  1. Current Progress in Clinical, Molecular, and Genetic Aspects of Adult Fibromuscular Dysplasia. Cardiovascular Research. 2022. Persu A, Dobrowolski P, Gornik HL, et al.
  2. First International Consensus on the Diagnosis and Management of Fibromuscular Dysplasia. Vascular Medicine. 2019. Gornik HL, Persu A, Adlam D, et al.
  3. The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients. Circulation. 2012. Olin JW, Froehlich J, Gu X, et al.
  4. Prevalence, Presentation, and Associated Conditions of Patients With Fibromuscular Dysplasia. The American Journal of Cardiology. 2019. Krittanawong C, Kumar A, Johnson KW, et al.
  5. Fibromuscular Dysplasia. The New England Journal of Medicine. 2004. Slovut DP, Olin JW.
  6. Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD. Journal of the American College of Cardiology. 2016. Kadian-Dodov D, Gornik HL, Gu X, et al.
  7. FMD and SCAD: Sex-Biased Arterial Diseases With Clinical and Genetic Pleiotropy. Circulation Research. 2021. Kim ESH, Saw J, Kadian-Dodov D, Wood M, Ganesh SK.
  8. Fibromuscular Dysplasia: Contemporary Concepts and Future Directions. Progress in Cardiovascular Diseases. 2018. Narula N, Kadian-Dodov D, Olin JW.

About Dr. Gerti Tashko, MD

Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.